MLchartDataset catalogue

Acridine carboxamide

Term · Oncology and biomedicine · MLC-T-ONC-000174

  1. A substance being studied in the treatment of cancer. It is a type of topoisomerase inhibitor. Also called DACA.

  2. A tricyclic acridine-based (or carboxamide-based) drug with dual topoisomerase inhibitor and potential antineoplastic activities. Acridine carboxamide inhibits both topoisomerases I and II and intercalates into DNA, resulting in DNA damage, the disruption of DNA repair and replication, the inhibition of RNA and protein synthesis, and cell death.

Table 1. Record
IdentifierMLC-T-ONC-000174
FieldOncology and biomedicine
AbbreviationDACA
SynonymsDACA
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-000174",
  "term": "Acridine carboxamide",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A substance being studied in the treatment of cancer. It is a type of topoisomerase inhibitor. Also called DACA.",
    "A tricyclic acridine-based (or carboxamide-based) drug with dual topoisomerase inhibitor and potential antineoplastic activities. Acridine carboxamide inhibits both topoisomerases I and II and intercalates into DNA, resulting in DNA damage, the disruption of DNA repair and replication, the inhibition of RNA and protein synthesis, and cell death."
  ],
  "abbreviation": "DACA",
  "synonyms": [
    "DACA"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/acridine-carboxamide/"
}

Record 276 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.